cardiovascularКардиоваскулярная терапия и профилактикаCardiovascular Therapy and Prevention1728-88002619-0125«SILICEA-POLIGRAF» LLC10.15829/1728-8800-2021-2932cardiovascular-2932Research ArticleМНЕНИЕ ПРИГЛАШЕННОГО РЕДАКТОРАOPINION OF INVITED EDITORОстрая ишемия нижних конечностей в условиях пандемии COVID-19Acute lower limb ischemia in the context of the COVID-19 pandemichttps://orcid.org/0000-0003-0433-2523ВинокуровИ. А.VinokurovI. A.
Доктор медицинских наук, доцент кафедры госпитальной хирургии Института клинической медицины им. Н. В. Склифосовского.
Москва
Moscow
docvin.med@gmail.comФГАОУ ВО Первый МГМУ им. И. М. Сеченова Минздрава России (Сеченовский Университет)I.M. Sechenov First Moscow State Medical University20211707202120429322932Copyright © Винокуров И.А., 20212021Винокуров И.А.Vinokurov I.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://cardiovascular.elpub.ru/jour/article/view/2932
.
COVID-19острая ишемия нижних конечностейтромбозCOVID-19acute lower limb ischemiathrombosisReferencesLu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565-74. doi:10.1016/S0140-6736(20)30251-8.Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565-74. doi:10.1016/S0140-6736(20)30251-8.Tang N, Li D, Wang X, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844-7. doi:10.1111/jth.14768.Tang N, Li D, Wang X, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844-7. doi:10.1111/jth.14768.Björck M, Earnshaw JJ, Acosta S, et al. European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia. Eur J Vasc Endovasc Surg. 2020;59(2):173-218. doi:10.1016/j.ejvs.2019.09.006.Björck M, Earnshaw JJ, Acosta S, et al. European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia. Eur J Vasc Endovasc Surg. 2020;59(2):173-218. doi:10.1016/j.ejvs.2019.09.006.Topcu AC, Ozturk-Altunyurt G, Akman D, et al. Acute Limb Ischemia in Hospitalized COVID-19 Patients. Ann Vasc Surg. 2021;S0890-5096(21)00233-8. doi:10.1016/j.avsg.2021.03.003.Topcu AC, Ozturk-Altunyurt G, Akman D, et al. Acute Limb Ischemia in Hospitalized COVID-19 Patients. Ann Vasc Surg. 2021;S0890-5096(21)00233-8. doi:10.1016/j.avsg.2021.03.003.Ilonzo N, Koleilat I, Prakash V, et al. The Effect of COVID-19 on Training and Case Volume of Vascular Surgery Trainees. Vasc Endovascular Surg. 2021;1538574420985775. doi:10.1177/1538574420985775.Ilonzo N, Koleilat I, Prakash V, et al. The Effect of COVID-19 on Training and Case Volume of Vascular Surgery Trainees. Vasc Endovascular Surg. 2021;1538574420985775. doi:10.1177/1538574420985775.Perini P, Nabulsi B, Massoni CB, et al. Acute limb ischaemia in two young, non-atherosclerotic patients with COVID-19. Lancet. 2020;395(10236):1546. doi:10.1016/S0140-6736(20)31051-5.Perini P, Nabulsi B, Massoni CB, et al. Acute limb ischaemia in two young, non-atherosclerotic patients with COVID-19. Lancet. 2020;395(10236):1546. doi:10.1016/S0140-6736(20)31051-5.Gubitosa JC, Xu P, Ahmed A, et al. COVID-19-Associated Acute Limb Ischemia in a Patient on Therapeutic Anticoagulation. Cureus. 2020;12(9):e10655. doi:10.7759/cureus.10655.Gubitosa JC, Xu P, Ahmed A, et al. COVID-19-Associated Acute Limb Ischemia in a Patient on Therapeutic Anticoagulation. Cureus. 2020;12(9):e10655. doi:10.7759/cureus.10655.Bellosta R, Luzzani L, Natalini G, et al. Acute limb ischemia in patients with COVID-19 pneumonia. J Vasc Surg. 2020;72(6):1864-72. doi:10.1016/j.jvs.2020.04.483.Bellosta R, Luzzani L, Natalini G, et al. Acute limb ischemia in patients with COVID-19 pneumonia. J Vasc Surg. 2020;72(6):1864-72. doi:10.1016/j.jvs.2020.04.483.Sánchez JB, Cuipal Alcalde JD, Ramos Isidro R, et al. Acute Limb Ischemia in a Peruvian Cohort Infected by COVID-19. Ann Vasc Surg. 2021;72:196-204. doi:10.1016/j.avsg.2020.12.005.Sánchez JB, Cuipal Alcalde JD, Ramos Isidro R, et al. Acute Limb Ischemia in a Peruvian Cohort Infected by COVID-19. Ann Vasc Surg. 2021;72:196-204. doi:10.1016/j.avsg.2020.12.005.Aasen M, Blecha M. Percutaneous Revascularization for COVID-19 Induced Spontaneous Arterial Thrombosis. Vasc Endovascular Surg. 2021:15385744211010445. doi:10.1177/15385744211010445.Aasen M, Blecha M. Percutaneous Revascularization for COVID-19 Induced Spontaneous Arterial Thrombosis. Vasc Endovascular Surg. 2021:15385744211010445. doi:10.1177/15385744211010445.Гадеев А. К., Бредихин Р. А. Лечение больных с острой ишемией нижних конечностей: селективный тромболизис или открытые хирургические вмешательства? Ангиология и сосудистая хирургия. 2015;4:37-4.Gadeev AK, Bredikhin RA. Treatment of patients with acute ischemia of the lower extremities: selective thrombolysis or open surgery? Angiology and Vascular Surgery. 2015;4:37-4. (In Russ.)Максимов А. В., Гайсина Э. А., Нуретдинов Р. М. Регионарный тромболизис при острой ишемии нижних конечностей. Практическая медицина. 2018;16(7-2):55-8.Maksimov AV, Gaysina EA, Nuretdinov RM. Regional thrombolysis in case of acute lower limb ischemia. Practical Medicine. 2018;16(7-part 2):55-8. (In Russ.)Hippensteel JA, LaRiviere WB, Colbert JF, et al. Heparin as a therapy for COVID-19: current evidence and future possibilities. Am J Physiol Lung Cell Mol Physiol. 2020;319(2):L211-7. doi:10.1152/ajplung.00199.2020.Hippensteel JA, LaRiviere WB, Colbert JF, et al. Heparin as a therapy for COVID-19: current evidence and future possibilities. Am J Physiol Lung Cell Mol Physiol. 2020;319(2):L211-7. doi:10.1152/ajplung.00199.2020.Anand SS, Eikelboom JW, Dyal L, et al. Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial. J Am Coll Cardiol. 2019;73(25):3271-80. doi:10.1016/j.jacc.2019.02.079.Anand SS, Eikelboom JW, Dyal L, et al. Rivaroxaban Plus Aspirin Versus Aspirin in Relation to Vascular Risk in the COMPASS Trial. J Am Coll Cardiol. 2019;73(25):3271-80. doi:10.1016/j.jacc.2019.02.079.Barnes GD, Burnett A, Allen A, et al. Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum. J Thromb Thrombolysis. 2020;50(1):72-81. doi:10.1007/s11239-020-02138-z.Barnes GD, Burnett A, Allen A, et al. Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum. J Thromb Thrombolysis. 2020;50(1):72-81. doi:10.1007/s11239-020-02138-z.
The authors declare that there are no conflicts of interest present.